Acusphere, Inc.
ACUS
$0.00
$0.000.00%
| Weiss Ratings | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jul 12, 2023 | |||
| 52-Week High Price (Date) | Jul 12, 2023 | |||
| Valuation | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -10.59 | |||
| Earnings Per Share Growth | -27.02% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.72M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -1.18% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617-648-8800 | |||
| Address | 500 Arsenal Street Watertown, MA 02472 | |||
| Website | www.acusphere.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,837.43% | |||
| Profit Margin | -1,874.95% | |||
| Management Effectiveness | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -64.27% | |||
| Return on Equity | -- | |||
| Income Statement | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.53M | |||
| Total Revenue (TTM) | 2.53M | |||
| Revenue Per Share | $0.54 | |||
| Gross Profit (TTM) | -31.42M | |||
| EBITDA (TTM) | -36.23M | |||
| EBIT (TTM) | -46.43M | |||
| Net Income (TTM) | -47.38M | |||
| Net Income Avl. to Common (TTM) | -47.94M | |||
| Total Revenue Growth (Q YOY) | -49.18% | |||
| Earnings Growth (Q YOY) | 26.56% | |||
| EPS Diluted (TTM) | -10.59 | |||
| EPS Diluted Growth (Q YOY) | 28.27% | |||
| Balance Sheet | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.11M | |||
| Cash Per Share (Q) | $0.87 | |||
| Total Current Assets (Q) | 5.70M | |||
| Total Preferred Equity (Q) | 0.01 | |||
| Total Equity (Q) | -10.33M | |||
| Current Ratio (Q) | 0.290 | |||
| Book Value Per Share (Q) | -$2.15 | |||
| Total Assets (Q) | 22.80M | |||
| Total Current Liabilities (Q) | 19.63M | |||
| Total Debt (Q) | 13.47M | |||
| Total Liabilities (Q) | 33.13M | |||
| Total Common Equity (Q) | -10.34M | |||
| Cash Flow | ACUS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -321.00K | |||
| Cash from Financing (TTM) | -6.89M | |||
| Net Change in Cash (TTM) | -35.40M | |||
| Levered Free Cash Flow (TTM) | -19.87M | |||
| Cash from Operations (TTM) | -28.18M | |||
